Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
Clinical trial NCT00841204 · COMPLETED
Trial details
- NCT number
- NCT00841204
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.